Difference between revisions of "Upper tract urothelial carcinoma"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
'''Upper tract urothelial carcinoma''', is a [[urothelial carcinoma]] that involves the upper urinary tract (ureter, pelvis, kidney). It is a considered a rare disease.<ref name=pmid24319507>{{cite journal |authors=Kapoor A, Allard CB, Black P, Kassouf W, Morash C, Rendon R |title=Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma |journal=Can Urol Assoc J |volume=7 |issue=9-10 |pages=306–11 |date=2013 |pmid=24319507 |pmc=3854466 |doi=10.5489/cuaj.1578 |url=}}</ref> | '''Upper tract urothelial carcinoma''' (abbreviated '''UTUC'''), is a [[urothelial carcinoma]] that involves the upper urinary tract (ureter, pelvis, kidney). It is a considered a rare disease.<ref name=pmid24319507>{{cite journal |authors=Kapoor A, Allard CB, Black P, Kassouf W, Morash C, Rendon R |title=Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma |journal=Can Urol Assoc J |volume=7 |issue=9-10 |pages=306–11 |date=2013 |pmid=24319507 |pmc=3854466 |doi=10.5489/cuaj.1578 |url=}}</ref> | ||
==General== | ==General== | ||
Latest revision as of 18:34, 3 September 2024
Upper tract urothelial carcinoma (abbreviated UTUC), is a urothelial carcinoma that involves the upper urinary tract (ureter, pelvis, kidney). It is a considered a rare disease.[1]
General
- Low-grade upper tract urothelial carcinoma may be managed via endoscopic approaches.[2]
- May be associated with Lynch syndrome - MMR testing typically indicated.
See also
References
- ↑ Kapoor A, Allard CB, Black P, Kassouf W, Morash C, Rendon R (2013). "Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma". Can Urol Assoc J 7 (9-10): 306–11. doi:10.5489/cuaj.1578. PMC 3854466. PMID 24319507. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854466/.
- ↑ Argyropoulos AN, Tolley DA (May 2007). "Upper urinary tract transitional cell carcinoma: current treatment overview of minimally invasive approaches". BJU Int 99 (5): 982–7. doi:10.1111/j.1464-410X.2007.06870.x. PMID 17437430.